Search Results

JK-P3 25 mg  | 99.50%

TargetMol

JK-P3 is a pyrazole-based inhibitor of VEGFR-2 (IC50: 7.8 μM). JK-P3 inhibits FGFR 1/3 kinase activity in vitro, but has no effect on FGFR signaling in cell-based assays. The compound blocks wound healing and tube formation in HUVEC without effecting endothelial cell proliferation.

More Information Supplier Page

Batimastat 10 mg  | 98.55%

TargetMol

Batimastat (BB-94) is an effective, broad-spectrum matrix metalloprotease (MMP) inhibitor. Batimastat induces extracellular matrix degradation and inhibits angiogenesis, tumor growth and invasion, and metastasis.

More Information Supplier Page

ML-18 5 mg  | 100.00%

TargetMol

ML-18 is a non-peptide bombesin receptor subtype-3 (BRS-3) antagonist with an IC50 of 4.8 μM.

More Information Supplier Page

ML-18 50 mg  | 100.00%

TargetMol

ML-18 is a non-peptide bombesin receptor subtype-3 (BRS-3) antagonist with an IC50 of 4.8 μM.

More Information Supplier Page

ML-18 25 mg  | 100.00%

TargetMol

ML-18 is a non-peptide bombesin receptor subtype-3 (BRS-3) antagonist with an IC50 of 4.8 μM.

More Information Supplier Page

ML-18 10 mg  | 100.00%

TargetMol

ML-18 is a non-peptide bombesin receptor subtype-3 (BRS-3) antagonist with an IC50 of 4.8 μM.

More Information Supplier Page